Detalhe da pesquisa
1.
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 16(15): 1493-1505, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474518
2.
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(12): e2346094, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051531
3.
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma.
Nat Commun
; 13(1): 5020, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028483
4.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
JAMA Oncol
; 6(6): 831-838, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32379280
5.
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
JAMA Oncol
; 4(9): 1214-1220, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955792
6.
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone.
Can Urol Assoc J
; 10(3-4): 102-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27217856